Signal transducers and activators of transcription (Stat) 5a and 5b proteins play an essential role in hematopoietic cell proliferation and survival and are frequently constitutively active in hematologic neoplasms and solid tumors. Because Stat5a and Stat5b differ mainly in the carboxyl-terminal transactivation domain, we sought to identify new proteins that bind specifically to this domain by using a bacterial two-hybrid screening. We isolated hTid1, a human DnaJ protein that acts as a tumor suppressor in various solid tumors. hTid1 interacts specifically with Stat5b but not with Stat5a in hematopoietic cell lines. This interaction involves the cystein rich region of the hTid1 DnaJ domain. We also demonstrated that hTid1 negatively regulates the expression and transcriptional activity of Stat5b and suppresses the growth of hematopoietic cells transformed by an oncogenic form of Stat5b. Our findings define hTid1 as a novel partner and negative regulator of Stat5b.
Signal transducers and activators of transcription (Stat) 5a and 5b proteins play an essential role in hematopoietic cell proliferation and survival and are frequently constitutively active in hematologic neoplasms and solid tumors. Because Stat5a and Stat5b differ mainly in the carboxyl-terminal transactivation domain, we sought to identify new proteins that bind specifically to this domain by using a bacterial two-hybrid screening. We isolated hTid1, a human DnaJ protein that acts as a tumor suppressor in various solid tumors. hTid1 interacts specifically with Stat5b but not with Stat5a in hematopoietic cell lines. This interaction involves the cystein rich region of the hTid1 DnaJ domain. We also demonstrated that hTid1 negatively regulates the expression and transcriptional activity of Stat5b and suppresses the growth of hematopoietic cells transformed by an oncogenic form of Stat5b. Our findings define hTid1 as a novel partner and negative regulator of Stat5b.
Stat transcription factors play a central role in cytokine-dependent survival, proliferation and differentiation of a large spectrum of cells. Following cytokine addition, Stat proteins become tyrosine phosphorylated and subsequently dimerize forming homo or heterodimers, translocate into the nucleus where they bind to specific elements in the promoter of target genes and activate transcription (1) . The Stat protein family comprises seven members including the two closely related Stat5a and Stat5b molecules (2, 3) . Mice in which stat5a and stat5b genes were deleted revealed redundant and specific functions of both proteins. Stat5a-/-mice have a profound defect in mammary gland development and in prolactin response, while stat5b-/-mice display a defect in Growth Hormone response (4, 5) . Simultaneous inactivation of stat5a/b genes demonstrated the requirement of both proteins in myeloid and lymphoid cell proliferation (6, 7) . Indeed, erythroblasts, myeloid cells, mast cells, peripheral T cells, NK cells and B cells display impaired proliferation and/or survival in mice lacking expression of Stat5 proteins (8) (9) (10) (11) . Stat5 promotes cell survival and/or proliferation by regulating the expression of genes involved in the control of cell cycle and survival like bcl-x L , cyclins D1 and D2, p21 waf1 and the proto-oncogene pim-1 (12) (13) (14) . Beside the physiological role of Stat5 in hematopoietic cell development, there is increasing evidence suggesting that inappropriate activation of Stat5 may contribute to the development of leukemias and solid cancers (15, 16) . Stat5 is frequently hyperactivated in cancer and leukemias most probably by alterations of tyrosines kinases activities. Importantly, Stat5 is a common and crucial target for different oncoproteins with tyrosine kinase activity, like Tel-Jak2, Bcr-Abl, the mutated forms of Flt3 and c-Kit and the Jak2V617F mutant (17) (18) (19) (20) (21) . Furthermore, it was shown that Stat5 plays a critical role in Bcr-Abl-and Tel-Jak2-induced myeloproliferative disease (22, 23) . The most direct evidence that constitutive activation of Stat5 is an important causative event in cell transformation came from the analysis of the Stat5 mutants, Stat5a1*6 Stat5b1*6 and cS5 F . These proteins with mutations at residues H 299 ->R and S 711/716 ->F (Stat5a1*6 or Stat5b1*6) or with the single mutation S 711 ->F (cS5 F ) possess constitutive tyrosine phosphorylation and are capable to induce leukemias in mice (23, 24) . In addition, Stat5b plays an important role in the proliferation and/or survival of tumor cells from head and neck cancer, glioblastomas, prostate cancer (16, (25) (26) (27) . Stat5b acts downstream of epidermal growth factor receptor (EGF-R) which is frequently overexpressed or hyperactivated in these tumors (28). Furthermore, Stat5b is specifically activated in T-cell lymphomas transformed by the oncogenic fusion NPM1-ALK and contributes to the NPM1-ALK oncogenesis by promoting cell growth and survival while Stat5a acts as a tumor suppressor in these malignant cells (29) . This suggests that Stat5a and Stat5b may have some non overlapping and opposite functions in the transformation of similar target cells. Like other Stats family members, Stat5a and Stat5b proteins contain in their carboxylterminal part a transactivation domain which is required for transcriptional activation (30) . In some early hematopoietic progenitors and in peripheral T cells, cleavage of full length Stat5 proteins by proteases generate C-terminally truncated Stat5 proteins called Stat5γ that lack the transactivation domain and function as dominant negative proteins (3) . Mutagenesis analysis have shown that a small amphipathic α-helical region within this domain is not only required for transcriptional activation of Stat5 proteins, but also for the rapid proteasomedependent turnover of the molecules (31) . This region is also involved in the recruitment of the cofactors CBP/P300 and NCoA1/SRC-1 (32, 33) . Thus, transcriptional activation and down-regulation of Stat5 proteins are mediated via a similar region located in the transactivation domain. Stat5a and Stat5b share 96% homology at the amino-acid level and differ mainly in the carboxyl-terminal region. Importanly, a serine residue at position 779 which is phosphorylated in Stat5a is absent at a similar position in Stat5b (34) . There are evidences that Stat5b is phosphorylated on tyrosine residues in the COOH terminus distinct from the residue Y699 which is necessary for Stat5b dimerization and activation (35) . Such phosphorylations may eventually affect Stat5b intracellular trafficking or interaction with cellular proteins (36) . The carboxyl-terminal regions of Stat5a and Stat5b may therefore confer distinct functions to these two molecules that might be related in part to interactions with distinct molecular partners. In this work, we aimed to identify new Stat5 transactivation domaininteracting proteins that could differentially regulate Stat5a or Stat5b activity. For this purpose, we used a bacterial two-hybrid screening approach. We have identified hTid1, a human DnaJ protein, homolog of the drosophila tumor suppressor Tid56, as a novel and specific negative regulator of Stat5b activity and expression in hematopoietic cell lines.
EXPERIMENTAL PROCEDURES.
Bacterial two-hybrid screening-Murine sequences encoding the transactivation domain of Stat5a and Stat5b (amino acids 724-794 and 728-786 respectively) were amplified by PCR from pXM-Stat5a and pXM-Stat5b plasmids and subcloned into the Not I / Xho I sites of the BacterioMatch TM (Stratagene) two-hybrid bait vector pBT, creating pBT-Stat5a and pBTStat5b. The human Jurkat T cells cDNA library cloned into the pTRG vector was purchased from Stratagene. The screening procedures were performed according to the manufacturer's recommendations (Stratagene). Briefly, the bacterial reporter strain containing the HIS3-aadA cassette was cotransformed with pBTStat5a or pBT-stat5b constructs and the pTRG plasmids that were amplified and purified from the cDNA library. Transformed bacterias were then plated on selective medium lacking histidine and containing 3-amino-1,2,4-triazole (3-AT, Sigma), a competitive inhibitor of the His3 enzyme. The false positives were eliminated by expressing the aadA gene, which confers streptomycine resistance, as a secondary reporter. pBT-LGF2 and pTRGGal11 P vectors were used as positive controls. DNA plasmids from positive clones obtained after two rounds of screening were isolated and sequenced. Cell cultures and reagents-COS cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (Biological Industries), 2mM L-glutamine, 10U/ml penicillin, 10µg/ml streptomycin (Life Technologies). Parental Ba/F3 cells and the Ba/F3 cell line expressing Stat5b1*6 or Stat5a1*6 were maintained in RPMI medium as previously described (37 (38) were introduced into the psiRNA-h7SKGFPzeo vector (Invivogen). In transient transfection assays, the psiRNATid1-h7SKGP or control psiRNAluc-h7SKGFP constructs (25 μg) were electroporated in Ba/F3 cells (250V, 960μF). Electroporated cells were expanded for 24 h in medium and the GFP+ cells were sorted by flow cytometry (Elite, Becton-Dickinson). Proliferation and viability were then examined by counting viable cells using the trypan blue dye exclusion method. The (-344 to -1) β−casein gene promoterluciferase construct, the LHRR plasmid containing 6 copies of the Stat5-binding site linked to the minimal Tk-luciferase reporter gene, the expression vectors for murine Stat5 (pXM-Stat5a andpXM-Stat5b), and the long form of the murine prolactine receptor have been described previously (30) . For the coimmunoprecipitation studies, COS cells were transfected by the calcium phosphate method with 5 µg of Stat5 expression vector (pXMStat5 or pIRES-hrGFP-Stat5) and 5 µg of hTid1 L or hTid1 S expression vector (pCMV-hTid1 L/S or pIRES-hrGFP-hTid1 L/S ). Transfected cells were extensively washed in PBS and lysed in NP-40 buffer as previously described. For the luciferase assays, COS cells were transfected with 25 ng of of STAT5 and hTid1 expression vectors, 20 ng of the luciferase constructs, and 30 ng of the prolactine receptor plasmid. 24h after transfection, cells were stimulated overnight with or without 1µg/ml of prolactine, and then lysed in 20 µl of luciferase lysis buffer (25mM tris-orthophosphate, 8mM MgCl2, 1mM DTT, 0.1% Triton X-100, 15% glycerol). The luciferase activities were measured in a luminometer (Berthold, PerkinElmer).
Immunoprecipitation and Western Blot-
Whole cell extracts were separated by SDS-PAGE and blotted onto cellulose membrane (Hybond-C super membrane; Amesham Life Science). Blots were incubated with antibodies raised against: Stat5b and Stat5a (Zymed, San Francisco, CA, USA), FLAG (Stratagene), actin (C-11), hTid1 S/L , hTid1 S and hTid1 L, Bcl-X L (Santa Cruz Bio-technology). Immunoprecipitation experiments were performed as previously described (39) .
RESULTS

Identification of hTid1 as a Stat5b-interacting protein-
To analyze the regulation and function of Stat5a and Stat5b, we sought to identify proteins that specifically interact with the COOH-terminal transactivation domain of these two molecules using the BacterioMatch TM two-hybrid system ( Figure  1A ). Screening of a human Jurkat T cell cDNA library with the transactivation domain of Stat5b (aa728-786) as bait, allowed us to isolate four positive clones that were identified to encode the DnaJ domain of hTid1, the human homolog of the drosophila tumor suppressor Tid56. The specificity of this interaction was further confirmed by cotransformation of bacterias with the pBTStat5a or pBT-Stat5b constructs and the pTRG-B6 plasmid DNA encoding the DnaJ domain of hTid1 ( Figure 1B ). Only bacterias containing both pBT-Stat5b and pTRG-B6 or the positive control plasmids (pBT-LGF2 and pTRG-Gal) were able to grow on selective medium (-His, +3AT). Physiological association of Stat5b and hTid1 in various cell types-The htid1 gene encodes two spliced variants of hTid1, a long form hTid1 L and a short form hTid1 S (40) . To verify the interaction of Stat5b with hTid1 L or hTid1 S , we first transfected COS cells with expression vectors encoding hTid1 S , the flagged-tag form of Stat5a or Stat5b or the control empty plasmids. Expression of Stat5a, Stat5b and hTid1 was first analyzed by Western Blot with an anti-Flag antibody and an anti-hTid1 antibody that recognizes both the long and short forms of hTid1. Expression of endogenous hTid1 L and hTid1 S was observed in mock-transfected COS cells (Figure 2A , left part). The level of hTid1 S protein was further increased after transfection with the Tid1 S construct. An additional protein with an apparent molecular weight of 45 kDa corresponding to the non-processed form of hTid1 S was also detected (u-hTid1 S ). Cell lysates were next immunoprecipitated with an anti-hTid1 antibody and the presence of Stat5a or Stat5b in the immunoprecipitates was determined by Western blot with the anti-Flag antibody ( Figure 2A ). Expression of Stat5b and very weakly of Stat5a was detected in hTid1 S immunoprecipitates. Similar results were obtained when COS cells were transfected with an hTid1 L expression vector (Data not shown). We then analyzed whether endogenous Stat5 transcription factors interact with hTid1 in three human and murine lymphoid cell lines that express Stat5a and Stat5b : the human Jurkat T, the murine Ba/F3 pro-B and the 697 human pre-B cell lines. In these cells, Stat5a and Stat5b have been previously shown to be phosphorylated and to regulate cell growth and survival upon stimulation with IL2, IL3 and IL7 (12, 41) . We found that Stat5b but not Stat5a interacted with hTid1 in all 3 cell lines, albeit weakly in the Jurkat T cell line ( Figure 2B ). We next determined whether each of the hTid1 isoforms, hTid1 L and hTid1 S associates with Stat5b in Ba/F3 and 697 cells. For this purpose, hTid1 L or hTid1 S were first immunoprecipitated with specific antibodies from both types of cells, Ba/F3 and 697 cell extracts and the presence of Stat5b was detected by Western blotting ( Figure 2C ). In keeping with the results obtained in transfected COS cells, hTid1 L and hTid1 S were found to interact with Stat5b in these cells. To analyze the specificity of the Stat5b/hTid1 interaction, we determined the presence of Stat1, Stat3 and Stat6 in the anti-hTid1 immunoprecipitates ( Figure 2D ). Only Stat1 but not Stat3 or Stat6 was found to interact with hTid1 in Ba/F3 and 697 cells. We then determined whether or not cytokineinduced tyrosine phosphorylation of Stat5b could affect the association between Stat5b and hTid1. hTid1 was immunoprecipitated from Ba/F3 cells unstimulated or stimulated with IL-3 for 30 min and the co-immunoprecipitation of Stat5b was next determined by Western blotting. Results clearly showed that the interaction between hTid1 and Stat5b was disrupted in cytokine-stimulated cells. ( Figure  3A) . A Similar expriment was conducted in the 697 pre-B cells which enabled us to demonstrate that IL-7-induced tyrosine phosphorylation of Stat5b was also associated with the loss of Stat5b and hTid1 interaction ( Figure 3B ). In sharp contrast, treatment of Ba/F3 and 697 cells with IL-3 and IL-7 respectively, did not change the association between Stat1 and hTid1 although both cytokines were able to induce tyrosine phosphorylation of this transcription factor ( Figure 3C and data not shown). Furthermore, we brought evidence that the cytokine-induced phosphorylation of Y 699 on Stat5b is involved in the dissociation of this transcription factor from hTid1 (Suppl. Figure 1) . Collectively, our findings showed that Stat5b specifically interacts with hTid1 in lymphoid cells and that Y 699 phosphorylation on Stat5b negatively regulates this association. hTid1 inhibits the transcriptional activity of Stat5b-Because hTid1 interacts with the COOH-terminal transactivation domain of Stat5b, we tested wether hTid1 could interfere with the transcriptional activity of Stat5b. To evaluate this effect, increasing amounts of hTid1 S expression vector were co-transfected in COS cells with expression vectors for Stat5b together with the prolactin receptor and the Stat5-regulated β-casein promoter-luciferase construct.
After prolactin stimulation, luciferase activity was determined in transfected cell extracts ( Figure 4A ). Results clearly showed that hTid1 inhibits luciferase activity in a dose-dependent fashion. A similar experiment was conducted with a multimerized Stat5 binding sites coupled to a Tk promoter luciferase construct ( Figure 4B ). We showed that increasing amounts of hTid1 plasmids strongly inhibited Stat5b-induced and weakly affected Stat5a-induced luciferase activity. These data indicated that hTid1 preferentially and negatively regulates Stat5b transcriptional activity in transfected COS cells. To  further delineate the  regions of hTid1 interacting with Stat5b, we generated different flagged tagged mutants of hTid1 L that were deleted in the NH2-terminal-DnaJ domain, the central DnaJ-cystein rich region and/or the COOH-terminal DnaJ domain ( Figure 5A ). These different mutants and the wild-type form hTid1 L were introduced into the bi-cistronic expression vector carrying the GFP protein (pIREShrGFP) and then co-transfected with a Stat5b expression vector in COS cells. Expression of these mutants were first analyzed by Western blotting with an anti-FLAG antibody. All mutants were expressed with an expected molecular weight in transfected COS cells ( Figure 5B, left panel) . We then analyzed their association with Stat5b. For this, Stat5b was immunoprecipitated from the different cell lysates and the co-immunoprecipitation of the hTid1 mutants was determined by Western blot with an anti-Flag antibody. Results showed that the mutant carrying the deletion ΔN150 was able to interact with Stat5b but not the mutants lacking the central DnaJ-cystein rich domain, indicating that this region plays an important role in the association between hTid1 and Stat5b ( Figure 5B, right panel) . We then determined whether these mutants could affect transcriptional activity of Stat5b. Stat5b and the hTid1 contructs were co-transfected in COS cells together with the Stat5 reporter construct and the prolactin receptor. After prolactin stimulation, luciferase activity was measured in transfected cell extracts ( Figure  5C ). Expression of wt-hTid1 S and hTid1 S ΔN150 inhibited luciferase activity, while expression of mutants hTid S Δcys or hTid1 S ΔC233 did not or weakly affected luciferase activity. Altogether, these data indicated that hTid1 functionally interacts with Stat5b via the central cystein rich region of hTid1. hTid1 inhibits expression of Stat5b in Ba/F3 cells-It has been previously shown that hTid1 as a co-chaperonne molecule regulates the stability and activity of different viral and cellular proteins (42) (43) (44) . We therefore analyzed by Western Blot whether hTid1 could affect expression of Stat5b in Ba/F3 cells ( Figure 6A ). We found that expression of Stat5b was down regulated in Ba/F3 cells after transient expression of hTid1 L or hTid1 S . In sharp contrast, expression of Stat5a was not affected. Conversely, we also analyzed the effect of hTid1 knock-down on Stat5b expression. Ba/F3 cells were transfected with a hTid1-shRNA or a control luciferase-shRNA expression vectors carrying a GFP reporter. GFP + cells were sorted after transfection and expression of Stat5b was then evaluated by Western blot analysis. Abrogation of hTid1 expression by means of specific shRNA resulted in the up-regulation of Stat5b expression in Ba/F3 cells. We then analyzed the contribution of the DnaJ cystein rich region of hTid1 to the regulation of Stat5b expression in Ba/F3 cells. To do this, we compared the effects of the hTid1 S Δcyst mutant and the wild type form of hTid1 S on Stat5b expression. Results showed that the mutant hTid1 S Δcyst fails to inhibit expression of Stat5b providing evidence that the DnaJ cystein rich region is involved in the Stat5b down regulation induced by hTid1 S or hTid1 L ( Figure 6C ). Collectively, these data showed that hTid1 regulates Stat5b expression in hematopoietic cells via its DnaJ cystein-rich region. Figure 7A ). Expression of hTid1 L and to a lesser extent hTid1 S, inhibited Ba/F3 cell growth, without altering cell survival. Strikingly, this inhibitory effect was more pronounced in Ba/F3 cells transformed by the Stat5b1*6 mutant than by the Stat5a1*6 mutant (suppl. Figure 2) . We next determined whether this growth inhibitory effect also involves the central DnaJ cystein rich region. Ba/F3 cells or Stat5b1*6-expressing Ba/F3 cells were electroporated with hTid1 L , hTid L Δcys, hTid1 L ΔC233 expression vector or empty vector as control. 24 hrs later, cells were sorted by flow cytometry and growth rates were determined 48 hrs later. Results clearly indicated that deletion of the central DnaJ cystein rich region of hTid1 L almost restored the normal proliferation of Ba/F3 cells and Ba/F3 cells expressing Stat5b1*6 ( Figure 7B ).
hTid1 interacts with Stat5b through the cystein-rich region of the DnaJ domain-
To further demonstrate that the central DnaJ cystein rich region is crucial for this growth inhbitory effect, we expressed a hTid1 mutant containing only the DnaJ cystein rich region from amino acid 220 to amino acid 303 (hTid1cys(220-303) in Ba/F3 cells ( Figure  7C ). Results showed that expression of this mutant is as efficient as wild-type hTid1 L to inhibit the cell growth. We next detemined whether this mutant could block transcriptional activity of Stat5 by analysing expression of Bcl-x L , a previously identified Stat5 target gene in Ba/F3 cells (12) (Figure 7D ). Both wild-type hTid1 L and hTid1Cys(220-303) were able to inhibit expression of this anti-apoptotic molecule. Collectively these data indicated that hTid1 inhibits Stat5b-mediated proliferation and transcriptional activity in Ba/F3 cells through its DnaJ-cystein rich region.
DISCUSSION
Stats transcription factors are important mediators of cytokine-induced cell survival and proliferation. They transmit signals emanating from activated receptors to the nucleus in a rapid and transient manner (1) . Stats activities are switched-off subsequently by several and distinct negative regulatory mechanisms. These include the activities of phosphatases, suppressors of cytokines signalling (SOCS), interaction of inhibitory proteins such as protein inhibitor of activated Stats (PIAS) and targeted proteasomedependent degradation of active Stats (45) (46) (47) . For instance, it was shown that tyrosine dephosphorylation of Stat5 is induced by distinct tyrosine phosphatases like SHP-2, PTP1B, LMW-PTP (48) (49) (50) . In addition, targeted proteasome-degradation of Stat5 is mediated via their ubiquitinylation (47) . Interestingly, The carboxyl-terminal region of Sat5 containing the transactivation domain is involved in the dephosphorylation induced by the phosphatase LMW-PTP (50) . Similarly, nuclear ubiquitinylation and degradation of Stat5a by a yet unidentified E3-ubiquitin ligase requires the alpha amphipathic helix present in the transactivation domain of Stat5 (51) . To identify specific binding of proteins to the carboxyl-terminal region of Stat5a and Stat5b, we used a bacterial two hybrid screening and identified hTid1 as an interacting partner of Stat5b but not Stat5a. hTid1 has a high homology to Tid56, the protein encoded by the Drosophila Melanogaster tumor suppressor gene l(2)tid (52) . Tid56 and hTid1 have 65,8 and 54,9 % amino acid similarity and identity, respectively, and thus have been well conserved through evolution (53) . Tid56 and hTid1 are members of DnaJ chaperone protein family which contains J domain, a highly conserved domain that bind to Hsp70 molecular chaperones (54) . The DnaJ/Hsp70 complexes are involved in protein folding, protein degradation and in the assembly or disassembly of multiprotein complexes. The htid1 gene encodes two spliced variants of hTid1, hTid1 L and hTid1 S, with opposite functions (40) . We showed in this study that both forms of hTid1 were able to interact with Stat5b in different murine and human hematopoietic cell lines and in COS cells co-expressing Stat5b and hTid1. Lu et al., reported that only the long form of hTid1 interacts with Stat1 and Stat3 in the U2OS osteosarcoma cells (55) . Our data showed that both forms of hTid1 interact with Stat1 but not Stat3 in hematopoietic cell lines. The reason for these discrepancies is not known but may be due to the requirement of an unidentified additional partner that is missing in some types of cells. In sharp contrast to Stat1, association of hTid1 isoforms with Stat5b is no longer detected following cell stimulation with cytokines. Phosphorylation of Stat5b on tyrosine residue Y 699 was further shown to be involved in the dissociation of Stat5b from hTid1 upon cytokine stimulation. Nevertheless, we observed that hTid1 inhibits the transcriptional activity of Stat5b but not Stat5a in transfected COS cells, providing evidence for a specific and functional interaction between hTid1 and Stat5b. Importantly, we brought evidence that hTid1 had the ability to inhibit the expression of Stat5b. Many studies have emphasized the important role of hTid1 in the regulation of stability and/or degradation of cellular proteins. For example, it was shown that hTid1 allowed the degradation of the transcription factor HIF1α by the Von Hippel Lindau protein (43) . Similarly hTid1 may prolong the half-life of IκB kinases or act on the degradation of the receptor Erb2 in breast carcinoma cells (42, 56) . It is therefore conceivable that hTid1 can regulate the stability/degradation of Stat5b. hTid1 interacts with the chaperonnes molecules Hsc70 and Hsp70 (40, 55) . Interestingly, it was previously shown that overexpression of Hsp70 protein in leukemic cells increases the expression of Stat5 (57) . Thus, it is likely that hTid1 may act on Stat5b expression via interaction with Hsp70, a hypothesis that awaits further experiments.
Our mutagenesis experiments clearly demonstrated that the DnaJ cystein-rich region of hTid1 is essential in the downregulation of Stat5b expression and activity. This central cystein-rich domain resembles a zinc finger structure and contains 4 repeats of the motif CXXCXGXG (X represents any amino acid). Previous reports have shown that this region also interacts with the HTLV viral protein Tax and the transcription factor Smad7, a downstream signaling effector of BMP (Bone Morphogenetic Protein) (58, 59) . Interestingly, interaction with Smad7 was shown to alter the development of chicken embryos by inhibiting the signaling induced by BMP. Although the DnaJ cystein-rich domain is essential for the hTid1/Stat5b interaction, we cannot rule out the contribution of the DnaJ domain NH2-terminus in regulating the expression of Stat5b since this domain plays a role in the targeted degradation of intracellular proteins as it has been observed for the IκB / IKK complex (42) . Although the physiological function of hTid1 in hematopoietic cells remains currently poorly documented, our findings and published reports suggest that hTid1 may regulate the proliferation and or survival of hematopoietic cells (60) . Importantly, we showed that hTid1 can inhibit the growth of Ba/F3 cells transformed by an oncogenic Stat5b but not a Stat5a mutant. There is a body of evidence indicating that hTid1 plays an important role in apoptosis and /or cell proliferation in various cell types (38, 40) . In addition, it was shown that hTid regulates apoptosis of glioma cells and suppresses growth of head and neck cancer cells both in vitro and in vivo (61, 62) . The mechanisms involved in hTid1-mediated growth suppression remains elusive since hTid1 modulates the activity of many proteins involved in signal transduction and hence in the survival / apoptosis and / or cell proliferation. Indeed, hTid1 regulates the activity and /or stability of the tyrosine kinase JAK2, the IKK/IKβ complex and therefore the activation of NFκB as well as the HIF1α transcription factor (42, 43, 63) . In addition, hTid1 interacts with the tumor suppressor APC (Adenomatous Polyposis Coli) and regulates the activity of p53 by affecting its subcellular localization (64, 65) . Our data suggest that hTid1 inhibits the growth of hematopoietic cell lines by interfering with the Stat5-dependent expression of genes involved in cell proliferation and survival such as Bcl-x L . Interestingly, several reports have shown that Stat5b but not Stat5a plays an important role in the proliferation and/or tumor invasion of glioblastoma multiforme cells and that constitutive activation of Stat5b contributes to squamous cell tumorigenesis in vitro and in vivo (25, 26) . The apparent opposite effects of hTid1 in these two types of tumors suggest that hTid1 interferes with Stat5b activity in these neoplastic cells. In conclusion, our findings identified hTid1 as a new partner of Stat5b that has the ability to inhibit its transcriptional activity and its effects on hematopoietic cell growth. Whether hTid1 could suppress Stat5b-mediated cell transformation needs to be investigated. The finding that the 83 aminoacids containing DnaJ cystein-rich region of hTid1 constitute the unique Stat5b-interacting domain opens interesting perspectives in the development of short peptides that could block the oncogenic activity of Stat5b. The following day, GFP + cells were sorted and the levels of Stat5a and Stat5b were next determined by immunoblotting with specific antibodies. Membranes were reprobed with an anti-actin antibody. Expression of hTid1 L and hTid1 S was also verified by Western blot with an anti-Flag antibody (the two bands represent the mature and unprocessed forms of the Flag-tagged hTid1 L or hTid1 S protein). B) Ba/F3 cells were electroporated with the pSiRNAhTid1-h7SKGFP plasmid or the pSiRNA-luch7SKGFP construct as control. GFP + cells were sorted by flow cytometry and expression levels of hTid1 and Stat5b were then analysed by Western blot using indicated antibodies. The membrane was reprobed with an anti-actin antibody. C) hTid1 L and hTid1 L Δcys constructs were transfected in Ba/F3 cells. After cell sorting, expression of Stat5b was determined by Western blot using an anti-Stat5b antibody. Levels of hTid1 L and hTid1 L Δcys proteins were also determined by Western blot with an anti-Flag antibody (the two bands represent the mature and unprocessed forms of the Flag-tagged hTid1 L or hTid1 L Δcys protein). Membrane was reprobed with an anti-actin antibody. α-actin
